Currently out of the existing stock ratings of Justin Smith, 9 are a BUY (60%), 5 are a HOLD (33.33%), 1 are a SELL (6.67%).

Justin Smith

Work Performance Price Targets & Ratings Chart

Analyst Justin Smith, currently employed at SOCGEN, carries an average stock price target met ratio of 82.14% that have a potential upside of 35.18% achieved within 472 days.

Justin Smith’s has documented 34 price targets and ratings displayed on 10 stocks. The coverage is on Healthcare, Communication Services sectors.

Most recent stock forecast was given on BMY, Bristol-Myers Squibb Company at 11-Mar-2024.

Wall Street Analyst Justin Smith

Analyst best performing recommendations are on SE (SEA LTD).
The best stock recommendation documented was for SE (SEA LTD) at 1/9/2023. The price target of $60 was fulfilled within 4 days with a profit of $6.96 (13.12%) receiving and performance score of 32.81.

Average potential price target upside

BMY Bristol-Myers Squibb Company GSK GlaxoSmithKline PLC ADR AZN AstraZeneca PLC ADR ABBV AbbVie SE Sea Ltd FMS Fresenius Medical Care GMAB Genmab AS FSNUY Fresenius SE KGaA ADR RHHBY Roche Holding Ltd ADR MRK Merck mpany

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 17-Nov-2022

$60

$-2.37 (-3.80%)

$52

9 days ago
(25-Feb-2026)

4/7 (57.14%)

$-1.6 (-2.60%)

186

Buy Since 22-Apr-2025

$75

$12.63 (20.25%)

$66

11 days ago
(23-Feb-2026)

0/3 (0%)

$13.75 (22.45%)

Buy Since 12-Dec-2025

$72

$9.63 (15.44%)

$62

1 months ago
(06-Feb-2026)

3/12 (25%)

$10.01 (16.15%)

789

Hold Since 03-Jan-2024

$64

$1.63 (2.61%)

$51

1 months ago
(06-Feb-2026)

6/13 (46.15%)

$2.01 (3.24%)

988

Hold Since 10-Dec-2021

$60

$-2.37 (-3.80%)

$55

1 months ago
(06-Feb-2026)

8/10 (80%)

$-1.99 (-3.21%)

150

Show more analysts

Please expand the browser size to see the chart

What Year was the first public recommendation made by Justin Smith?

On 2017

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?